Teriflunomide for relapsing remitting multiple sclerosis

E-ISSN： 1931-2253|26|18|11-14

ISSN： 0959-6682

Source： PRESCRIBER, Vol.26, Iss.18, 2015-09, pp. : 11-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging Therapies in Relapsing-Remitting Multiple Sclerosis

Reviews on Recent Clinical Trials, Vol. 5, Iss. 3, 2010-09 ,pp. : 179-188

Bentham Science Publishers

Access to resources Recommend Favorite

The clinical importance of neutralizing antibodies in relapsing-remitting multiple sclerosis

By Namaka Mike Pollitt-Smith Merinda Gupta Aneri Klowak Meghann Vasconcelos Marcus Turcotte Dana Gong Yuewen Melanson Maria

Current Medical Research and Opinion, Vol. 22, Iss. 2, 2006-02 ,pp. : 223-239

Informa Healthcare

Access to resources Recommend Favorite

Assessment of new application system in Portuguese patients with relapsing-remitting multiple sclerosis

By de Sá J. Urbano G. Reis L.

Current Medical Research and Opinion, Vol. 26, Iss. 9, 2010-09 ,pp. : 2237-2242

Informa Healthcare

Access to resources Recommend Favorite

Switch to natalizumab versus fingolimod in active relapsing–remitting multiple sclerosis

ANNALS OF NEUROLOGY, Vol. 77, Iss. 3, 2015-03 ,pp. : 425-435

John Wiley & Sons Inc

Access to resources Recommend Favorite

Overview of the management of relapsing−remitting multiple sclerosis and practical recommendations

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 22, Iss. S2, 2015-10 ,pp. : 14-21

John Wiley & Sons Inc

Access to resources Recommend Favorite